Extended Data Fig. 10: BLI response between neutralizing-antibody-based drugs and the RBD of SARS-CoV-2 wild type, Beta or Omicron strains. | Nature

Extended Data Fig. 10: BLI response between neutralizing-antibody-based drugs and the RBD of SARS-CoV-2 wild type, Beta or Omicron strains.

From: Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Extended Data Fig. 10

Antibodies were captured by Protein A sensor. The concentrations of RBD are shown in different colours. Dissociation constant (KD), association constant (ka), and dissociation rate constant (kd) are labelled. Neutralizing antibodies without binding are marked as ‘Escaped’.

Back to article page